ABSTRACT
Objective To determine the characteristics and outcomes of Covid-19 patients at Livingstone teaching hospital.
Methods A database cross sectional review of COVID 19 patients at Livingstone Teaching Hospital. Data on demographics and clinical characteristics were obtained along with the comorbidities presented with by the patients using a structured data collection form. Data were analysed using STATA 64. Mann-Whitney and t-test were used on continuous independent variables. Chi-square test was used to determine associations between two categorical variables. Logistic regression was used to control for confounders.
Results A total of 222 (62.54%) were male and 133 (37.46%) were female. Discharged were 274 (77.18%), while 81 (22.82%) died. Among those who died were the older clients with a median age of 65 (p <0.001). The median interquartile range (IQR)] age was 48.5 years. Patients presented with a cough 180 (50.7%), chest pain 123 (34.65%) and shortness of breath 121 (34.04%). Statistically significant comorbidities recorded included Hypertension 121 (34.08%), Diabetes mellitus 69 (19.44%), and HIV 38 (10.7%). The most prevalent underlying condition observed was hypertension 121 (34.08).
Conclusion HIV positive and diabetics had an increased odds of succumbing to COVID-19 death. It is recommended that targeted policies should be considered the risky groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
this study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by University of Lusaka, School of Medicine & Health Sciences Research Ethics Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Guarantor of Submission: The corresponding author is the guarantor of submission.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
